Evotaz Tablet
Product Images NDC 0003-3641

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Evotaz (NDC 0003-3641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ataza Cobic Label.png

Label for EVOTAZ tablets containing atazanavir and cobicistat with strengths of 300 mg and 150 mg respectively. The label includes warnings to take with food and pharmacist notes, storage instructions, and manufacturer information for Bristol-Myers Squibb Company. The package contains 30 tablets, and the product is made in Canada.*

FDA Label Image

Atazanavir Chemical Structure (Atazanavir Structure)

Chemical structure of atazanavir and cobicistat (EVOTAZ), showing the molecular bonds and functional groups of the active ingredients.*

FDA Label Image

Cobicistat Chemical Structure (Cobicistat Structure)

Chemical structure of the active ingredients in EVOTAZ, atazanavir and cobicistat, depicted as a molecular formula diagram showing atoms and bonds in the combined compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.